Job strain and effort-reward imbalance linked to higher risk of atrial fibrillation

Work-related stress caused by job strain and an imbalance between efforts applied vs. rewards received may increase the risk of developing atrial fibrillation, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

BridgeBio Oncology Therapeutics launches with $200m funding

The investment aims to expedite the development of the company’s precision oncology pipeline. Credit: Alex_Traksel / Shutterstock.com. BridgeBio Pharma has announced the launch of BridgeBio

May 3, 2024

How GLP-1’s moved from research labs to national TV

Today is the inaugural publishing day for Adam’s Biotech Scorecard — a subscriber-only newsletter offering senior reporter Adam Feuerstein’s no-holds-barred perspective on the rapidly shifting

March 28, 2024

Eli Lilly targets Scorpion Therapeutics to expand reach in oncology – Pharmaceutical Technology

Eli Lilly has announced plans to acquire Scorpion Therapeutics’ PI3Kα inhibitor program. Credit: Michael Vi via Shutterstock. Eli Lilly will buy Boston biotech Scorpion Therapeutics’

January 13, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.